Literature DB >> 11054201

Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial.

J A Feldman1, S S Fish, J R Beshansky, J L Griffith, R H Woolard, H P Selker.   

Abstract

STUDY
OBJECTIVE: To describe the characteristics of a large group of patients who presented to emergency departments with cocaine-associated symptoms consistent with acute cardiac ischemia (ACI) and to determine the incidence of confirmed ACI including acute myocardial infarction (AMI) in this population.
METHODS: We performed a substudy on all patients in a multicenter prospective clinical trial (the Acute Cardiac Ischemia-Time Insensitive Predictive Instrument [ACI-TIPI] Clinical Trial) that enrolled ED patients with chest pain or other symptoms consistent with ACI including subjects with identified cocaine use. Demographic and clinical features, including initial and follow-up clinical data, ECGs, and tests to determine serum creatine kinase isoenzyme MB subunit concentrations, were analyzed. Diagnoses of AMI followed the World Health Organization criteria for AMI and of angina pectoris, the Canadian Cardiovascular Society Classification.
RESULTS: Of the 10,689 patients enrolled in the trial, 293 (2.7%) had cocaine-associated complaints. Among the 10 participating hospitals, the incidence of patients with cocaine-associated symptoms varied from 0.3% to 8.4%. Only 6 patients (2.0%, 95% confidence interval [CI] 0.76% to 4.4%) had a diagnosis of ACI; 4 (1.4%, 95% CI 0.37% to 3.5%) had unstable angina, and 2 (0.7%, 95% CI 0.08% to 2.4%) had AMI. Although patients with cocaine-induced complaints were as likely to be admitted to the coronary care unit compared with all study patients without cocaine use (14% versus 18%, P =.14, difference not significant), these patients were much less likely to have confirmed unstable angina (1.4% versus 9.3%, P <.001) or AMI (0. 7% versus 8.6%, P <.001). Compared with patients younger than 45 years, patients with cocaine usage were more likely to be admitted to the ICU (14% versus 8.0%, P =.0018) but less likely to have confirmed AMI (0.7% versus 2.8%, P =.033).
CONCLUSION: Patients presenting to EDs with cocaine-associated chest pain or related symptoms infrequently had ACI, and even less so, AMI. This suggests the need for selectivity in the hospitalization of patients with such cocaine-associated symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 11054201     DOI: 10.1067/mem.2000.110994

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  14 in total

1.  Assessment of myocardial infarction by CT angiography and cardiovascular MRI in patients with cocaine-associated chest pain: a pilot study.

Authors:  K Paraschin; A Guerra De Andrade; J Rodrigues Parga
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

Review 2.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

3.  A Double Whammy: Severe Aortic Stenosis and Cocaine Overwhelm the Mitral Valve.

Authors:  Rohit Maini; Jonathan Lim; Jing Liu; Itamar Birnbaum; Farooq Mirza; Nasser Lakkis; Ihab Hamzeh
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jan-Mar

4.  Cocaine-using patients with a normal or nondiagnostic electrocardiogram: single-photon emission computed tomography myocardial perfusion imaging and outcome.

Authors:  Robert C Hendel; Robin Ruthazer; Sandra Chaparro; Claudia Martinez; Harry P Selker; Joni R Beshansky; James E Udelson
Journal:  Clin Cardiol       Date:  2012-02-23       Impact factor: 2.882

5.  Cocaine use and the likelihood of cardiovascular and all-cause mortality: data from the Third National Health and Nutrition Examination Survey Mortality Follow-up Study.

Authors:  Adnan I Qureshi; Saqib A Chaudhry; M Fareed K Suri
Journal:  J Vasc Interv Neurol       Date:  2014-05

Review 6.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association.

Authors:  Ezra A Amsterdam; J Douglas Kirk; David A Bluemke; Deborah Diercks; Michael E Farkouh; J Lee Garvey; Michael C Kontos; James McCord; Todd D Miller; Anthony Morise; L Kristin Newby; Frederick L Ruberg; Kristine Anne Scordo; Paul D Thompson
Journal:  Circulation       Date:  2010-07-26       Impact factor: 29.690

7.  Identification of very low-risk acute chest pain patients without troponin testing.

Authors:  Lane M Smith; Nicklaus P Ashburn; Anna C Snavely; Jason P Stopyra; Kristin M Lenoir; Brian J Wells; Brian C Hiestand; David M Herrington; Chadwick D Miller; Simon A Mahler
Journal:  Emerg Med J       Date:  2020-08-04       Impact factor: 2.740

8.  Predicting cardiovascular risk using a novel risk score in young and middle-age adults with HIV: associations with biomarkers and carotid atherosclerotic plaque.

Authors:  Violeta J Rodriguez; John M Abbamonte; Manasi S Parrish; Deborah L Jones; Stephen Weiss; Suresh Pallikkuth; Michal Toborek; Maria L Alcaide; Dushyantha Jayaweera; Savita Pahwa; Tatjana Rundek; Barry E Hurwitz; Mahendra Kumar
Journal:  Int J STD AIDS       Date:  2021-11-02       Impact factor: 1.456

9.  Impact of an abbreviated cardiac enzyme protocol to aid rapid discharge of patients with cocaine-associated chest pain in the clinical decision unit.

Authors:  Faheem W Guirgis; Kelly Gray-Eurom; Teri L Mayfield; David M Imbt; Colleen J Kalynych; Dale F Kraemer; Steven A Godwin
Journal:  West J Emerg Med       Date:  2014-03

Review 10.  Nonatherosclerotic causes of acute coronary syndrome: recognition and management.

Authors:  Teresa Bastante; Fernando Rivero; Javier Cuesta; Amparo Benedicto; Jorge Restrepo; Fernando Alfonso
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.